Why did LANXESS report a wider net loss in Q2 2026 despite higher sales and improved EBITDA?

LANXESS reported a widened net loss of €53 million in Q2 2026 because, although sales rose and EBITDA pre exceptionals increased significantly (by 61.7% quarter-on-quarter), the company still faced substantial cost pressures—including higher raw material and energy costs—and the prior-year comparison included an insurance reimbursement in the high single-digit million-euro range that boosted prior-year earnings; additionally, the Advanced Intermediates segment saw EBITDA pre exceptionals fall by 20.5% due to higher energy costs and inventory reduction efforts, offsetting gains elsewhere.

What does LANXESS’s unchanged full-year 2026 EBITDA guidance of €450–550 million indicate about its outlook for the remainder of the year?

LANXESS’s decision to maintain its full-year 2026 EBITDA pre exceptionals guidance of €450 million–550 million indicates cautious optimism: while it expects no sustained recovery in demand across core markets and continues to face challenging market conditions, it anticipates greater contributions from ongoing cost-reduction programs in the second half, which should help stabilize earnings despite persistent headwinds like elevated energy costs and weak macroeconomic momentum.

Germany’s LANXESS Q2 net loss widens despite higher sales

Aug 7, 2026

German specialty chemicals maker LANXESS reported a widened Q2 net loss of €53 million despite 13.3% sales growth, as price hikes offset rising raw material and energy costs. Full-year EBITDA guidance remains unchanged amidst challenging market conditions.

icis

2025-11-06

Lanxess downgrades earnings guidance, announces additional cost-cutting measures

2026-04-02

CW75 Chemical Index Rises 3.36%, Lanxess Shares Surge

2026-05-07

Lanxess Maintains 2026 Forecast, Sees Positive Impact of Middle East War on Demand

2026-08-07

Germany’s LANXESS Q2 net loss widens despite higher sales

Germany’s LANXESS Q2 net loss widens despite higher sales

FAQ